Lodestar Private Asset Management’s AbbVie ABBV Stock Holding History

Lodestar Private Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	4,198 -258	-6%	-$55.5K	0.09%	109
2026 Q1	$969K	Sell	4,456 -236	-5%	-$52.4K	0.1%	106
2025 Q4	$1.07M	Sell	4,692 -297	-6%	-$67.7K	0.11%	97
2025 Q3	$1.16M	Sell	4,989 -117	-2%	-$23.8K	0.12%	93
2025 Q2	$948K	Sell	5,106 -265	-5%	-$49.3K	0.11%	101
2025 Q1	$1.13M	Sell	5,371 -193	-3%	-$37.5K	0.14%	94
2024 Q4	$989K	Sell	5,564 -25	-0.4%	-$4.6K	0.12%	100
2024 Q3	$1.1M	Buy	5,589 +6	+0.1%	+$1.12K	0.14%	92
2024 Q2	$958K	Sell	5,583 -194	-3%	-$32.1K	0.13%	99
2024 Q1	$1.05M	Sell	5,777 -107	-2%	-$18.4K	0.15%	95
2023 Q4	$912K	Sell	5,884 -55	-0.9%	-$8.02K	0.14%	95
2023 Q3	$885K	Sell	5,939 -187	-3%	-$27.5K	0.15%	94
2023 Q2	$825K	Buy	6,126 +2,667	+77%	+$391K	0.14%	98
2023 Q1	$551K	Buy	3,459 +92	+3%	+$14.1K	0.1%	115
2022 Q4	$544K	Buy	+3,367	New	+$516K	0.1%	117

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lodestar Private Asset Management's ABBV Position: Q2 2026 in Review

Lodestar Private Asset Management reduced its AbbVie (ABBV) stake by 5.8% in Q2 2026, selling an estimated $55.5K and leaving 4,198 shares worth $1.06M. The position accounts for 0.09% of the portfolio, ranked #109.

Lodestar Private Asset Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.16M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lodestar Private Asset Management held 4,198 shares of AbbVie worth $1.06M as of Q2 2026.
Lodestar Private Asset Management sold 258 AbbVie shares in Q2 2026, an estimated $55.5K.
AbbVie made up 0.09% of Lodestar Private Asset Management's portfolio in Q2 2026, its #109 holding.
Lodestar Private Asset Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Lodestar Private Asset Management's AbbVie position peaked at $1.16M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lodestar Private Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.